New data: resistance training — not just protein — is what actually preserves muscle during GLP-1 weight loss

The concern about GLP-1 medications and muscle loss is not new — trial data from STEP and SURMOUNT has shown for a while that lean mass can account for a quarter to nearly half of total weight lost. What has been missing is a clean answer to the follow-up question: how much of that loss is actually preventable, and by what, specifically? A 2026 systematic review and meta-analysis puts a number on it.

What the meta-analysis actually compared

The researchers pooled randomised controlled trials comparing incretin-based drug therapy against structured lifestyle interventions, then split the lifestyle-intervention data further by whether resistance training was part of the program. Lifestyle intervention alone produced an average proportional lean mass loss of 26.2% of total weight lost. Lifestyle intervention that included resistance training showed the most favourable body-composition profile in the whole analysis: 17.5% proportional lean mass loss — roughly a third less muscle lost per pound of total weight, for the same overall weight-loss goal.

Why lifting outperforms protein alone

Protein intake gives muscle the raw material to be preserved; it does not, by itself, give the body a reason to keep that muscle instead of burning it for energy during a deficit. Mechanical tension from resistance training is the signal that tells the body a muscle is still being used and is worth defending — which is almost certainly why the combined approach outperformed diet-only strategies by this margin, even though every arm in the analysis was still eating at a calorie deficit.

The honest caveats

The pooled data showed moderate heterogeneity between studies (I² = 68%), meaning trial protocols, drug types and training programs varied enough that this 17.5% figure is a useful signal rather than a precise universal number. The analysis also does not cleanly isolate resistance training’s effect while specifically on a GLP-1 drug versus during lifestyle-only weight loss — it strengthens the existing case rather than replacing it.

This is exactly why Misi’s GLP-1 guide already pairs a protein floor with a resistance-training minimum rather than treating either alone as sufficient — this new meta-analysis is confirmation of that approach with a real number attached, not a reason to change it.